- Home
- GCTS vs VANI Comparison
GCTS vs VANI Comparison
Compare GCTS & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GCTS | VANI |
|---|---|---|
| Founded | 1998 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.1M | 81.2M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | GCTS | VANI |
|---|---|---|
| Price | $1.29 | $1.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $3.50 | ★ $4.00 |
| AVG Volume (30 Days) | 127.8K | ★ 173.5K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,893,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,205.88 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.90 | $0.91 |
| 52 Week High | $2.76 | $1.92 |
Technical Indicators
Market Signals| Indicator | GCTS | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 37.85 | 50.05 |
| Support Level | $1.29 | $1.35 |
| Resistance Level | $1.49 | $1.49 |
| Average True Range (ATR) | 0.08 | 0.08 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 4.00 | 36.36 |
Price Performance
Historical ComparisonAbout GCTS GCT Semiconductor Holding Inc.
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.